ArticleScientific reports2025
Malaria pigment hemozoin drives M1 pro-inflammatory macrophage polarization in vitro.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Severe malaria, a high burden parasitic disease, is characterized by hyperproduction of proinflammatory cytokines, most likely generated by M1-polarized macrophages. Malaria pigment or hemozoin (HZ), a byproduct of heme detoxification in intra-erythrocytic parasites, is internalized by circulating monocytes and tissue macrophages, modulating their functions. Although the immunomodulatory properties of HZ have been described, its specific role in M1/M2 macrophage polarization remains unclear. This study aims to fill this gap by elucidating whether HZ modulates M1/M2 polarization, contributing to the strong inflammatory response in severe malaria. Primary human monocyte derived macrophages (MDM) and THP-1 cells differentiated into macrophages (dTHP-1) were stimulated with M1 or M2 signals in the presence of native HZ. Gene expression and protein secretion of TNF-α, IL-1β, CXCL8, IL-6, IL-10 and PPARG were evaluated by Real-Time PCR and ELISA, respectively. STAT6 phosphorylation was evaluated by western blot analysis. MDM and dTHP-1 showed a different polarisation response to classical M1/M2 stimuli and to HZ treatment. In both non-polarized (M0) MDM and dTHP-1, HZ induced an M1/pro-inflammatory phenotype, increasing gene expression and protein secretion of CXCL8, TNF-α, and IL-1β. In the presence of M1- or M2-polarizing stimuli, HZ further increased CXCL8 and IL-1β in MDM but not in dTHP-1, where TNF-α secretion was even reduced. HZ did not affect M2 markers (PPARG and IL10 expression, STAT6 phosphorylation) in any condition. This is the first in vitro study investigating the effect of HZ on macrophage polarization, showing its ability to promote M1 pro-inflammatory differentiation. Results vary across experimental models, emphasizing the importance of considering model-specific effects. Clarifying HZ's role remains crucial for understanding malaria pathogenesis and developing new immunomodulatory therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.